Antonia Loukousia

Ms. Antonia Loukousia

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
EAElissavet Anestiadou
Elissavet Anestiadou
EKEfstathios Kotidis
Efstathios Kotidis
IDIoanna Abba Deka
Ioanna Abba Deka
Dimitris TatsisDimitris Tatsis
Dimitris Tatsis
Chryssa BekiariChryssa Bekiari
Chryssa Bekiari
ACAngeliki Cheva
Angeliki Cheva
Mesh-augmented hernia repair is the gold standard in abdominal wall and hiatal/diaphragmatic hernia management and ranks among the most common procedures performed by general surgeons. However, it is associated with a series of drawbacks, including recurrence, mesh infection, and adhesion formation. To address these weaknesses, numerous biomaterials have been investigated for mesh coating. Platelet-rich plasma (PRP) is an autologous agent that promotes tissue healing through numerous cytokines and growth factors. In addition, many reports highlight its contribution to better integration of different types of coated meshes, compared to conventional uncoated meshes. The use of PRP-coated meshes for hernia repair has been reported in the literature, but a review of technical aspects and outcomes is missing. The aim of this comprehensive review is to report the experimental studies investigating the synergistic use of PRP and mesh implants in hernia animal models. A comprehensive literature search was conducted across PubMed/Medline, Web of Science, and Scopus without chronological constraints. In total, fourteen experimental and three clinical studies have been included. Among experimental trials, synthetic, biologic, and composite meshes were used in four, nine, and one study, respectively. In synthetic meshes, PRP-coating leads to increased antioxidant levels and collaged deposition, reduced oxidative stress, and improved inflammatory response, while studies on biological meshes revealed increased neovascularization and tissue integration, reduced inflammation, adhesion severity, and mechanical failure rates. Finally, PRP-coating of composite meshes results in reduced adhesions and improved mechanical strength. Despite the abundance of preclinical data, there is a scarcity of clinical studies, mainly due to the absence of an established protocol regarding PRP preparation and application. To this point in time, PRP has been used as a coating agent for the repair of abdominal and diaphragmatic hernias, as well as for mesh fixation. Clinical application of conclusions drawn from experimental studies may lead to improved results in hernia repair.

31 August 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
KZKonstantinos Zapsalis
Konstantinos Zapsalis
OIOrestis Ioannidis
Orestis Ioannidis
EAElissavet Anestiadou
Elissavet Anestiadou
MPMaria Pantelidou
Maria Pantelidou
KSKostas Siozos
Kostas Siozos
SAStamatis Angelopoulos
Stamatis Angelopoulos
Adipose tissue micrografts (ATM) and dermis micrografts (DMG) have emerged as promising autologous therapies in regenerative wound care, leveraging mechanically disaggregated cell–matrix constructs to modulate the wound microenvironment and promote tissue repair. This scoping review systematically analyzed clinical studies investigating ATMs and DMGs in acute and chronic wounds. Eight studies, comprising randomized controlled trials, observational studies, and case series, were identified, involving diverse wound types such as burns, ulcers, surgical dehiscence, and posttraumatic defects. All interventions utilized mechanical disaggregation (Rigenera® system) to produce micrografts, which were applied via perilesional injection, scaffold-assisted delivery, or topical administration. Outcomes consistently demonstrated accelerated re-epithelialization, enhanced angiogenesis, improved scar remodeling, and low complication rates. In select studies, micrografts were combined with platelet-rich fibrin or stromal vascular fraction, suggesting potential synergistic effects. While one randomized trial showed superior healing outcomes with DMGs over collagen scaffolds, others yielded mixed results, likely reflecting heterogeneity in methodology and outcome measures. Overall, the available clinical evidence supports the safety, feasibility, and biological activity of micrograft-based therapies. However, larger, standardized, and mechanistically driven studies are required to validate their efficacy and define optimal protocols across wound etiologies.

17 November 2025 in Asian Spine Journal
Verified
Journal Article
Open access
PDF file
SSStavros Stamiris
Stavros Stamiris
DSDimitrios Stamiris
Dimitrios Stamiris
EAElissavet Anestiadou
Elissavet Anestiadou
ASAthanasios Sarridimitriou
Athanasios Sarridimitriou
ACAngeliki Cheva
Angeliki Cheva
CKChristos Karampalis
Christos Karampalis
Lumbar interbody fusion is widely employed to treat degenerative spinal conditions. The procedure frequently involves the use of intervertebral cages to enhance segmental stability and facilitate spinal fusion. While bilateral cage placement has traditionally been the standard approach, recent studies have questioned its routine use. This meta-analysis aimed to determine whether unilateral cage placement offers comparable safety and efficacy to bilateral placement in lumbar interbody fusion. A comprehensive search of PubMed, Scopus, and Cochrane databases identified eight eligible randomized control trials involving 509 patients. The primary outcome was the spinal fusion rate. Secondary outcomes included surgery-related outcomes (operative time, estimated blood loss, length of stay), patientreported outcomes VAS, ODI, patient satisfaction), and complications. The analysis revealed no significant differences in successful spinal fusion rates between the two groups (p =0.41). Unilateral cage placement was significantly associated with shorter operation time (p <0.0001) and reduced estimated blood loss (p <0.0001). However, the length of hospital stay was not significantly affected by the number of cages used (p =0.05). Patient-reported outcomes, including Visual Analog Scale (VAS) for back pain (p =0.61), VAS for leg pain (p =0.64), Oswestry Disability Index score (p =0.18), and patient-reported rate of successful clinical outcomes (p =0.55), exhibited no substantial differences between the two groups. Patients in the unilateral group exhibited a lower overall risk of complications (p =0.03), but no difference in the risk of cage migration was noted between the two groups (p =0.97). Unilateral cage placement for lumbar interbody fusion is as effective as bilateral cage placement in achieving fusion, without compromising patient outcomes. Furthermore, it offers significant advantages, such as decreased operative time, blood loss, and complication risk.

1 July 2025 in Pathophysiology
Verified
Journal Article
Open access
PDF file
ESElyaa Saleh
Elyaa Saleh
NANour Abdelaziz
Nour Abdelaziz
MRMalaak Ramahi
Malaak Ramahi
ALAntonia Loukousia
Antonia Loukousia
TBTheodossios Birbilis
Theodossios Birbilis
Dimitrios N. KanakisDimitrios N. Kanakis
Dimitrios N. Kanakis
Amyloidosis, often referred to as “the great imitator”, is a condition characterized by the abnormal deposition of amyloid proteins in various tissues, potentially leading to organ dysfunction. When these deposits localize in the brain, they can disrupt neurological function and present with diverse clinical manifestations, making diagnosis particularly challenging. Cerebral amyloidosis is a rare entity that frequently mimics other neurological disorders, often resulting in significant delays in recognition and management. This case highlights the diagnostic challenge posed by cerebral amyloidosis and underscores its unique presentation. We present the case of a 76-year-old male with a history of rheumatoid arthritis (RA) who developed progressive right-sided weakness over several months. Three years prior, he experienced numbness on the right side of his face and upper limb. Initial imaging identified a small lesion in the left thalamic region, which was originally diagnosed as a glioma. However, due to the worsening of his clinical symptoms, further evaluation was warranted. Subsequent imaging revealed lesion growth, prompting a biopsy that ultimately confirmed the diagnosis of intracerebral amyloidoma. This case underscores the necessity of considering amyloidosis in the differential diagnosis of atypical neurological deficits, particularly in patients with systemic inflammatory conditions such as RA. The initial presentation of hemiparesis resembling a stroke, coupled with non-specific imaging findings and a prior misdiagnosis of glioma, highlights the complexity of cerebral amyloidosis. Only through brain biopsy was the definitive diagnosis established, emphasizing the need for improved diagnostic modalities to facilitate early detection. Further subtyping of amyloidosis, however, requires mass spectrometry-based proteomics or immunohistochemistry to accurately identify the specific amyloid protein involved. Clinicians should maintain a high index of suspicion for cerebral amyloidosis in patients with RA who present with progressive neurological deficits and atypical brain lesions. Early recognition and accurate diagnosis are essential to guiding appropriate management and improving patient outcomes.

10 October 2024 in Research Square
Verified
Preprint
Open access
PDF file
SSStavros Stamiris
Stavros Stamiris
DSDimitrios Stamiris
Dimitrios Stamiris
EAElissavet Anestiadou
Elissavet Anestiadou
ASAthanasios Sarridimitriou
Athanasios Sarridimitriou
ACAngeliki Cheva
Angeliki Cheva
CKChristos Karampalis
Christos Karampalis
Study design: Systematic review and meta-analysis Objective: To compare the safety and efficacy of unilateral versus bilateral cage placement in lumbar interbody fusion. Summary of background data: Lumbar interbody fusion is a common surgical procedure designed to treat chronic spinal conditions. The procedure often involves the use of intervertebral cages to increase stability and promote fusion. While bilateral cage placement has traditionally been favored, recent studies have questioned its necessity. Methods: A comprehensive search across PubMed, Scopus, and Cochrane databases identified eight eligible RCTs involving 509 patients. The primary outcome focused on the spinal fusion rate, whereas the secondary outcomes included surgery related outcomes (operative time, estimated blood loss, length of stay), patient-reported outcomes (visual Analog Scale, Oswestry Disability Index, patient satisfaction) and complications. Results: The analysis revealed no significant difference in successful spinal fusion rates between the two groups (p=0.41). Unilateral cage placement was associated with significantly shorter operation time (p<0.0001) and reduced estimated blood loss (p<0.0001), whereas hospital stay was not affected by the number of cages used (p=0.24). Patient-reported outcomes, including VAS back score (p=0.61), VAS leg score (p=0.64), ODI score (p=0.23) and patient rate of results (p=0.55) showed no substantial differences between the two groups. Patients in the unilateral group had a lower overall risk for complications (p=0.03), but no difference in the risk of cage migration was noted between the two groups (p=0,97). Conclusions: Unilateral cage placement in lumbar interbody fusion is as effective as bilateral for achieving fusion without compromising patient outcomes. Furthermore, offers significant advantages, including reduced operative time, blood loss and reduced risk for complications.